Abstract
The dopamine D2 receptor radiotracer [11C]Raclopride is used extensively in clinical and preclinical imaging. Currently, a wide range of methods to produce [11C]Raclopride have been developed using traditional vessel reactions as well as cartridge or captive solvent.
This work reports the optimisation of the production of [11C]Raclopride using a Synthra GPextent, comparing various methods. With optimised conditions, we were able to obtain 4±2% (ndc) yield of [11C]Raclopride (100 GBq [11C]CO2, n = 42) in 25 min. The radiochemical purity was >95% with specific activities of 135±41 MBq/nmol at end of synthesis.
Keywords: 11Carbon, GPextent, optimization, raclopride.
Current Radiopharmaceuticals
Title:Optimisation of [11C]Raclopride Production Using a Synthra GPextent System
Volume: 7 Issue: 2
Author(s): Gary Perkins, Rajeev Sheth, Ivan Greguric and Giancarlo Pascali
Affiliation:
Keywords: 11Carbon, GPextent, optimization, raclopride.
Abstract: The dopamine D2 receptor radiotracer [11C]Raclopride is used extensively in clinical and preclinical imaging. Currently, a wide range of methods to produce [11C]Raclopride have been developed using traditional vessel reactions as well as cartridge or captive solvent.
This work reports the optimisation of the production of [11C]Raclopride using a Synthra GPextent, comparing various methods. With optimised conditions, we were able to obtain 4±2% (ndc) yield of [11C]Raclopride (100 GBq [11C]CO2, n = 42) in 25 min. The radiochemical purity was >95% with specific activities of 135±41 MBq/nmol at end of synthesis.
Export Options
About this article
Cite this article as:
Perkins Gary, Sheth Rajeev, Greguric Ivan and Pascali Giancarlo, Optimisation of [11C]Raclopride Production Using a Synthra GPextent System, Current Radiopharmaceuticals 2014; 7 (2) . https://dx.doi.org/10.2174/1874471007666141021111635
DOI https://dx.doi.org/10.2174/1874471007666141021111635 |
Print ISSN 1874-4710 |
Publisher Name Bentham Science Publisher |
Online ISSN 1874-4729 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Childhood Psychiatric Disorders in North-India: Prevalence, Incidence and Implications#
Adolescent Psychiatry Energy Metabolism, Adult Neurogenesis and their Possible Roles in Alzheimer’s Disease: A Brief Overview
Current Topics in Medicinal Chemistry The Urokinase Receptor System, A Key Regulator at the Intersection between Inflammation, Immunity, and Coagulation
Current Pharmaceutical Design Development of Monoamine Oxidase B Inhibitors with Antiparkinson Activity
Current Physical Chemistry Development of RET Kinase Inhibitors for Targeted Cancer Therapy
Current Medicinal Chemistry The Role of STAT3 Signaling in Mediating Tumor Resistance to Cancer Therapy
Current Drug Targets Association Study of Serine Racemase Gene with Methamphetamine Psychosis
Current Neuropharmacology Melatonin and Synthetic Melatoninergic Agonists in Psychiatric and Age-associated Disorders: Successful and Unsuccessful Approaches
Current Pharmaceutical Design Treating Schizophrenia: Novel Targets for the Cholinergic System
CNS & Neurological Disorders - Drug Targets Adult Neurogenesis and Drug Therapy
Central Nervous System Agents in Medicinal Chemistry Inflammation and Immunology of the Vitreoretinal Compartment
Inflammation & Allergy - Drug Targets (Discontinued) Network Pharmacology Strategies Toward Multi-Target Anticancer Therapies: From Computational Models to Experimental Design Principles
Current Pharmaceutical Design Superior Neuroprotective Effects of Cerebrolysin in Nanoparticle-Induced Exacerbation of Hyperthermia-Induced Brain Pathology
CNS & Neurological Disorders - Drug Targets The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development
Current Molecular Medicine Targets of Anti-glucocorticoid Therapy for Stress-related Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Cortisol Regulation in Patients with Type 2 Diabetes and the Metabolic Syndrome
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Activation of Central Pain Pathways in Rheumatic Diseases: What We have Learned from Functional Neuroimaging Studies
Current Rheumatology Reviews Recent Innovations in Off-Road Intelligent Vehicles: In-Field Automatic Navigation
Recent Patents on Mechanical Engineering Mitochondrial Dysfunctions in Bipolar Disorder: Effect of the Disease and Pharmacotherapy
CNS & Neurological Disorders - Drug Targets The Anticholinesterase Activity of Three Local Food Spices and Their Anti-Alzheimer Application
Current Nutraceuticals